Latest
news
LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships
- Successful completion of the financial realignment enables full focus on growth and further strengthening operational excellence
- Planned investments in production and logistics will enhance efficiency, flexibility, and delivery capabilities
- Further international growth, including expansion into new markets, targeted
Ahlen, 25 June 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has successfully completed its financial realignment, establishing the foundation for the company’s stable and forward-looking development.
With the achievement of the final milestone, an intensive and demanding process has been successfully concluded. LR has fundamentally realigned its financing structure and significantly strengthened its capital base. An initial financing tranche of EUR 10 million was provided at the end of March, followed by a second tranche of the same amount in June.
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “The past months have been challenging for many parties involved. We are therefore particularly pleased to have successfully completed the company’s financial realignment. We would like to express our sincere gratitude to our sales partners, suppliers, employees, and investors who have accompanied and supported us throughout this period. With our newly established financing structure, we now have a substantially stronger foundation for the future. Our focus is now fully directed towards further strengthening our operational capabilities, driving growth, and sustainably enhancing collaboration with our partners.”
The new financing structure has enabled the company to significantly and sustainably reduce its debt level. Lower debt service requirements create additional flexibility for targeted investments in key future areas of the company. The most important planned initiatives include:
- Investments in production at the Ahlen site to strengthen capacity, efficiency, and flexibility, including the insourcing of a key product
- Further development and optimization of logistics processes to enhance efficiency, delivery performance, and service quality
- Targeted investments to support international growth, including expansion into new markets
Through these measures, LR is strengthening its position as a reliable partner throughout the entire value chain. The company also reaffirms its clear commitment to quality, delivery reliability, and sustainable growth. With the successful completion of the financial realignment, LR is opening a new chapter – built on a solid financial foundation, clear growth ambitions, and a consistent focus on the needs of its partners and customers.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF TEMPORARY WAIVERS AND SUPER SENIOR BRIDGE FINANCING
Ad-hoc Announcements - LR Health & Beauty SE | 2026-03-06 | 16:31 CET/CEST
Disclosure of an inside information according to Art. 17 of the Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR)
LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF TEMPORARY WAIVERS AND SUPER SENIOR BRIDGE FINANCING
Ahlen, 6 March 2026 – LR Health & Beauty SE (the “Company”) has, as of today, entered into further agreements with holders of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bondholders” and the “Bonds”) representing more than two thirds (2/3) of the nominal amount of the Bonds (the “Majority Bondholders”) and the Company's shareholder regarding a comprehensive restructuring of the Bonds and the Company’s capital structure (the “Restructuring”).
A comprehensive restructuring, such as the Restructuring, will take time to implement which means that the Company will be in need of bridge financing in an amount of EUR 10,000,000 until the Restructuring is implemented. Certain Bondholders have undertaken to provide a bridge financing in the amount of EUR 10,000,000, having a super senior ranking in relation to the Bonds (the "Super Senior Bridge Financing"). The Super Senior Bridge Financing is intended to be refinanced in connection with closing of the Restructuring. Such Super Senior Bridge Financing may or may not share the security and guarantee package of the Bonds under an intercreditor agreement (in part or in full) and may further benefit from certain Super Senior Bridge Financing only share security.
In addition, the Majority Bondholders agreed to further extend the standstill undertaking comprising, inter alia, that Bondholders shall not derive any rights from breaches of the maintenance test (including the leverage covenant) or from any non-payments of interest until end of June 2026 (subject to extension).
In light of the above, the Company has today initiated a written procedure (the “Written Procedure”) under the Bonds to implement the above by way of amendments to and temporary waivers under the terms and conditions for the Bonds.
The notice of the Written Procedure and further details are accessible on the Company’s website at https://ir.lrworld.com/en/bond/.
IR contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
End of inside information
LR HEALTH & BEAUTY SE ANNOUNCES SUCCESSFUL CONCLUSION OF THE WRITTEN PROCEDURE INITIATED ON 19 MAY 2026, FULLY SUBSCRIBED ISSUANCES OF SHARES AND BONDS, ADMISSION TO TRADING OF THE NEW BONDS AND REDEMPTION OF OUTSTANDING SUPER SENIOR BRIDGE BONDS
Ahlen, 5 June 2026 – On 19 May 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) among the holders of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bondholders” and the “Bonds”) in accordance with the terms and conditions of the Bonds for the purpose of carrying out a comprehensive restructuring of the Bonds and the Company’s capital structure.
The deadline for voting in the Written Procedure was 15:00 hrs CEST today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the amendments and the waivers in the Written Procedure.
Jörg Körfer, CEO of LR Health & Beauty SE, states: “The successful completion of the Written Procedure, the full subscription of the new bond tranche, and the full subscription of the new equity shares represent significant milestones on our path to successfully strengthen the Company’s capital structure. In this regard, the strong confidence from our stakeholders lays the foundation for us to now consistently drive forward the strategic and operational initiatives aimed at restoring and securing sustainable growth for the LR Group.”
Effectiveness of the Written Procedure
The amendments and waivers approved in the Written Procedure are conditional upon satisfaction of the following conditions, which are expected to be satisfied on or prior to 11 June 2026:
- completion of the EUR 11,764,705.88 (cash proceeds of EUR 10,000,000) share issue in Abydos S.à r.l. (the “Share Issue” and the “Parent”) and entry into the investment and shareholders' agreement by all investors in the Share Issue;
- transfer of all shares in the Company and the receivable under an existing EUR 4,000,000 shareholder loan from the Company’s existing shareholder to the Parent;
- entry into the amended and restated terms and conditions for the Bonds; and
- entry into the terms and conditions for the EUR 27,500,000 junior bonds to be issued by the Parent (the “Junior Bonds”).
Full Subscription of the Share Issue and the New Bond Issue
The Share Issue has been fully subscribed and is expected to be executed on 10 June 2026. The new bond issue of EUR 30,000,000 (total subscription price of EUR 10,000,000) under the amended and restated terms and conditions for the Bonds (the “New Bonds” and the “New Bond Issue”) has been fully subscribed and the New Bonds are expected to be issued on 17 June 2026.
Admission to Trading
The New Bonds are intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm and listed on the Open Market of the Frankfurt Stock Exchange as soon as practically possible after the issue date of the New Bonds which is expected to be 17 June 2026.
The Junior Bonds are expected to be issued on 15 June 2026. The Junior Bonds shall be admitted to trading on the Open Market of the Frankfurt Stock Exchange within sixty (60) calendar days (with an intention of thirty (30) calendar days) of the issue date of the Junior Bonds, and on the Regulated Market of Nasdaq Stockholm (or another Regulated Market) within twelve (12) months of the issue date of the Junior Bonds.
Redemption of the Super Senior Bridge Bonds
The Company hereby gives notice to the holders of the Company’s super senior bridge bonds (ISIN: NO0013739029) issued by the Company on 26 March 2026 (the "Super Senior Bridge Bonds") of the redemption in full of the Super Senior Bridge Bonds on 22 June 2026. The redemption of the Super Senior Bridge Bonds is conditional upon the completion of the Share Issue and the New Bond Issue.
For further information regarding the Written Procedure and the restructuring measures set out therein, please refer to the notice of the Written Procedure which is accessible on the Company's website at https://ir.lrworld.com/en/bond/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
IR Contact:
cometis AG
Thorben Burbach
Friedrichstrasse 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

"With innovative product solutions that cater to people’s growing health consciousness, we are fully on-trend."